Kevin Daniel Litcofsky

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Seres Therapeutics, Inc., Seres Health, Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Daniel Litcofsky. Retrieved from https://idiyas.com/inventor/kevin-daniel-litcofsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 8.2

ph-index = 8

Forward Citations = 538(Granted Patents)

Company Filing History:

15 out of 28

Seres Therapeutics, Inc.

Years Active: 2014-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12409197 - Synergistic bacterial compositions and methods of production and use thereof (2025-09-09),

2. 12083151 - Synergistic bacterial compositions and methods of production and use thereof (2024-09-10),

3. 11918612 - Synergistic bacterial compositions and methods of production and use thereof (2024-03-05),

4. 11666612 - Network-based microbial compositions and methods (2023-06-06),

5. 11464812 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-11),

6. 11458174 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-04),

7. 11458173 - Synergistic bacterial compositions and methods of production and use thereof (2022-10-04),

8. 11389490 - Synergistic bacterial compositions and methods of production and use thereof (2022-07-19),

9. 11266699 - Synergistic bacterial compositions and methods of production and use thereof (2022-03-08),

10. 10973861 - Compositions and methods (2021-04-13),

11. 10881696 - Network-based microbial compositions and methods (2021-01-05),

12. 10864235 - Synergistic bacterial compositions and methods of production and use thereof (2020-12-15),

13. 10258655 - Synergistic bacterial compositions and methods of production and use thereof (2019-04-16),

14. 10076546 - Network-based microbial compositions and methods (2018-09-18),

15. 9533014 - Synergistic bacterial compositions and methods of production and use thereof (2017-01-03),

Title: Kevin Daniel Litcofsky: Innovator in Therapeutic Microbial Compositions

Introduction

Kevin Daniel Litcofsky is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of therapeutic compositions, particularly focusing on microbial populations for health applications. With a total of 17 patents, Litcofsky's work is at the forefront of innovation in the treatment of dysbiosis in mammalian subjects, including humans.

Latest Patents

Among his latest patents, Litcofsky has developed synergistic bacterial compositions and methods of production and use thereof. These therapeutic compositions contain microbial populations aimed at the prevention, treatment, and reduction of symptoms associated with dysbiosis. His work emphasizes the importance of maintaining a healthy microbial balance in the body, which can significantly impact overall health.

Career Highlights

Litcofsky has worked with notable companies such as Seres Therapeutics, Inc. and Seres Health, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative health solutions. His dedication to improving health outcomes through microbial therapies is evident in his extensive patent portfolio.

Collaborations

Throughout his career, Litcofsky has collaborated with esteemed colleagues, including Matthew R. Henn and David N. Cook. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in therapeutic research.

Conclusion

Kevin Daniel Litcofsky stands out as a key figure in the field of therapeutic microbial compositions. His innovative patents and collaborations reflect his commitment to enhancing health through scientific research. His contributions are paving the way for future advancements in the treatment of dysbiosis and related health issues.

Profile summary based on public USPTO records.